232 filings
Page 12 of 12
8-K
vma miioor0
7 Jan 15
ContraVir Pharmaceuticals Granted FDA Meeting to Discuss Proposal for Phase 3 Trial of FV-100
12:00am
8-K
3dyfj 2dec2orzv58rui
18 Dec 14
Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157
12:00am
8-K
ip56tqfycn0m9usfw
16 Dec 14
ContraVir Pharmaceuticals Appoints Nathaniel Katz, M.D., Chairman of New Scientific Advisory Board Chair
12:00am
8-K
n1mf0i 0grdf6z73knoq
11 Dec 14
Other Events
12:00am
8-K
i59e3a2uevj9rhsb04
9 Dec 14
Other Events
12:00am
8-K
n7k536bzvgdun ru7to
2 Dec 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ju5xdpatx22jw1pgx10v
15 Oct 14
ContraVir Pharmaceuticals Closes $9.0 Million Financing to Advance Lead Shingles Candidate
12:00am
8-K
h9g65
22 Aug 14
Unregistered Sales of Equity Securities
12:00am
8-K
d6zk0od
26 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
iii3dgsk21slb
20 Mar 14
ContraVir Appoints James Sapirstein as Chief Executive Officer and Board Member
12:00am
8-K
fys4ojk78u xb
5 Feb 14
Entry into a Material Definitive Agreement
12:00am
8-K
z15biqey0yfj7
27 Nov 13
Departure of Directors or Certain Officers
12:00am